메뉴 건너뛰기




Volumn 5, Issue 4, 2012, Pages 541-546

The value of visfatin in the prediction of metabolic syndrome: A multi-factorial analysis

Author keywords

Insulin; Metabolic syndrome; Visfatin

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

EID: 84866139374     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-012-9373-8     Document Type: Article
Times cited : (19)

References (28)
  • 1
    • 33845971890 scopus 로고    scopus 로고
    • The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes
    • Lorenzo, C., Williams, K., Hunt, K. J., & Haffner, S. M. (2007). The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care, 30 (1), 8-13.
    • (2007) Diabetes Care , vol.30 , Issue.1 , pp. 8-13
    • Lorenzo, C.1    Williams, K.2    Hunt, K.J.3    Haffner, S.M.4
  • 2
    • 33847187395 scopus 로고    scopus 로고
    • Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus
    • Rader, D. J. (2007). Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. The American Journal of Medicine, 120(3 Suppl 1), S12-S18.
    • (2007) The American Journal of Medicine , vol.120 , Issue.3 SUPPL. 1
    • Rader, D.J.1
  • 3
    • 1542344902 scopus 로고    scopus 로고
    • Type 2 diabetes mellitus: A disease of the innate immune system? An update
    • Crook, M. (2004). Type 2 diabetes mellitus: a disease of the innate immune system? An update. Diabetic Medicine, 21(3), 203-207.
    • (2004) Diabetic Medicine , vol.21 , Issue.3 , pp. 203-207
    • Crook, M.1
  • 4
    • 70350188297 scopus 로고    scopus 로고
    • Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome
    • Maury, E., & Brichard, S. M. (2009). Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Molecular and Cellular Endocrinology, 314(1), 1-16.
    • (2009) Molecular and Cellular Endocrinology , vol.314 , Issue.1 , pp. 1-16
    • Maury, E.1    Brichard, S.M.2
  • 5
    • 52049098545 scopus 로고    scopus 로고
    • Visfatin: Structure, function and relation to diabetes mellitus and other dysfunctions
    • Adeghate, E. (2008). Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions. Current Medicinal Chemistry, 15(18), 1851-1862.
    • (2008) Current Medicinal Chemistry , vol.15 , Issue.18 , pp. 1851-1862
    • Adeghate, E.1
  • 6
    • 0027958452 scopus 로고
    • Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor
    • Samal, B., Sun, Y., Stearns, G., Xie, C., Suggs, S., & McNiece, I. (1994). Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Molecular and Cellular Biology, 14(2), 1431-1437.
    • (1994) Molecular and Cellular Biology , vol.14 , Issue.2 , pp. 1431-1437
    • Samal, B.1    Sun, Y.2    Stearns, G.3    Xie, C.4    Suggs, S.5    McNiece, I.6
  • 7
    • 23144455313 scopus 로고    scopus 로고
    • Visfatin: The missing link between intra-abdominal obesity and diabetes?
    • Sethi, J. K., & Vidal-Puig, A. (2005). Visfatin: the missing link between intra-abdominal obesity and diabetes? Trends in Molecular Medicine, 11(8), 344-347.
    • (2005) Trends in Molecular Medicine , vol.11 , Issue.8 , pp. 344-347
    • Sethi, J.K.1    Vidal-Puig, A.2
  • 9
    • 25844491778 scopus 로고    scopus 로고
    • Plasma visfatin concentrations and fat depot-specific mRNA expression in humans
    • Berndt, J., Kloting, N., Kralisch, S., Kovacs, P., Fasshauer, M., Schon, M. R., et al. (2005). Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes, 54(10), 2911-2916.
    • (2005) Diabetes , vol.54 , Issue.10 , pp. 2911-2916
    • Berndt, J.1    Kloting, N.2    Kralisch, S.3    Kovacs, P.4    Fasshauer, M.5    Schon, M.R.6
  • 10
    • 19944433652 scopus 로고    scopus 로고
    • Visfatin: A protein secreted by visceral fat that mimics the effects of insulin
    • Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., et al. (2005). Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science, 307(5708), 426-430.
    • (2005) Science , vol.307 , Issue.5708 , pp. 426-430
    • Fukuhara, A.1    Matsuda, M.2    Nishizawa, M.3    Segawa, K.4    Tanaka, M.5    Kishimoto, K.6
  • 11
    • 35549002189 scopus 로고    scopus 로고
    • Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme
    • Revollo, J. R., Korner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., et al. (2007). Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metabolism, 6(5), 363-375.
    • (2007) Cell Metabolism , vol.6 , Issue.5 , pp. 363-375
    • Revollo, J.R.1    Korner, A.2    Mills, K.F.3    Satoh, A.4    Wang, T.5    Garten, A.6
  • 13
    • 67649674970 scopus 로고    scopus 로고
    • Overexpression of visfatin/PBEF/Nampt alters wholebody insulin sensitivity and lipid profile in rats
    • Sun, Q., Li, L., Li, R., Yang, M., Liu, H., Nowicki, M. J., et al. (2009). Overexpression of visfatin/PBEF/Nampt alters wholebody insulin sensitivity and lipid profile in rats. Annals of Medicine, 41(4), 311-320.
    • (2009) Annals of Medicine , vol.41 , Issue.4 , pp. 311-320
    • Sun, Q.1    Li, L.2    Li, R.3    Yang, M.4    Liu, H.5    Nowicki, M.J.6
  • 16
    • 25144459980 scopus 로고    scopus 로고
    • The metabolic syndrome - A new worldwide definition
    • Alberti, K. G., Zimmet, P., & Shaw, J. (2005). The metabolic syndrome - a new worldwide definition. Lancet, 366(9491), 1059-1062.
    • (2005) Lancet , vol.366 , Issue.9491 , pp. 1059-1062
    • Alberti, K.G.1    Zimmet, P.2    Shaw, J.3
  • 17
    • 77953049724 scopus 로고    scopus 로고
    • Appropriate waist circumference cut-off points among Iranian adults: The first report of the Iranian National Committee of Obesity
    • Azizi, F., Khalili, D., Aghajani, H., Esteghamati, A., Hosseinpanah, F., Delavari, A., et al. (2010). Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity. Archives of Iranian Medicine, 13(3), 243-244.
    • (2010) Archives of Iranian Medicine , vol.13 , Issue.3 , pp. 243-244
    • Azizi, F.1    Khalili, D.2    Aghajani, H.3    Esteghamati, A.4    Hosseinpanah, F.5    Delavari, A.6
  • 18
    • 44449133335 scopus 로고    scopus 로고
    • Adolphe Quetelet (1796-1874) - The average man and indices of obesity
    • Eknoyan, G. (2007). Adolphe Quetelet (1796-1874)-the average man and indices of obesity. Nephrology, Dialysis, Transplantation, 23(1), 47-51.
    • (2007) Nephrology, Dialysis, Transplantation , vol.23 , Issue.1 , pp. 47-51
    • Eknoyan, G.1
  • 19
    • 34447560040 scopus 로고    scopus 로고
    • Visceral and subcutaneous adiposity: Are both potential therapeutic targets for tackling the metabolic syndrome?
    • Rodriguez, A., Catalan, V., Gomez-Ambrosi, J., & Fruhbeck, G. (2007). Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome? Current Pharmaceutical Design, 13(21), 2169-2175.
    • (2007) Current Pharmaceutical Design , vol.13 , Issue.21 , pp. 2169-2175
    • Rodriguez, A.1    Catalan, V.2    Gomez-Ambrosi, J.3    Fruhbeck, G.4
  • 21
    • 34447336403 scopus 로고    scopus 로고
    • Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome
    • Kowalska, I., Straczkowski, M., Nikolajuk, A., Adamska, A., Karczewska-Kupczewska, M., Otziomek, E., et al. (2007). Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Human Reproduction, 22(7), 1824-1829.
    • (2007) Human Reproduction , vol.22 , Issue.7 , pp. 1824-1829
    • Kowalska, I.1    Straczkowski, M.2    Nikolajuk, A.3    Adamska, A.4    Karczewska-Kupczewska, M.5    Otziomek, E.6
  • 27
    • 34548389205 scopus 로고    scopus 로고
    • Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans
    • Epub 2007 Jul 3
    • Meier, J. J., Holst, J. J., Schmidt, W. E., & Nauck, M. A. (2007). Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans. American Journal of Physiology. Endocrinology and Metabolism, 293(3), E849-E856. Epub 2007 Jul 3.
    • (2007) American Journal of Physiology. Endocrinology and Metabolism , vol.293 , Issue.3
    • Meier, J.J.1    Holst, J.J.2    Schmidt, W.E.3    Nauck, M.A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.